PARIS--(BUSINESS WIRE)--Regulatory News: Acticor Biotech (Paris:ALACT), a clinical stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies, today ...

Technvaio forecast the global agricultural biotechnology market is expected to grow by USD 25.30 billion during 2021-2025. This marks a significant market slow down compared to the 2019 growth ...

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies, today ...

Welcome back to the working world, friends, I hope that you survived the return to the desk in good stead and are both warm and healthy. The current boom in COVID cases is a huge bummer, but perhaps ...

After seeing the successes of the likes of Pfizer (PFE) and Moderna (MRNA) in the news practically every day during this second year of the pandemic, the casual observer could be forgiven for assuming ...

Insider got exclusive data on the highest-paid CEOs in the pharma and biotech industries in 2021. The research firm MyLogIQ identified 15 CEOs that made at least $25 million last year. These leaders ...

EQS-News: BRAIN Biotech AG / Key word(s): Annual Results/Annual Report BRAIN Biotech AG reports record figures in fiscal year 2021/22 despite challenging geopolitical environment 16.01.2023 / 07:30 ...

For the last few years, Hong Kong has been the preferred financial hub for many Chinese health care companies to go public and raise money from global investors. “Biotechnology is today the ...

The FDA approval of Biogen's Alzheimer's disease drug Aduhelm was the biggest surprise. Several COVID-19 vaccine stocks skyrocketed well beyond expectations. Relatively few mergers and acquisitions ...

The Nasdaq Biotechnology Index (NBI™) was launched on Nov. 1, 1993, when the biotech industry was still in its relative infancy and prone to heightened volatility. Ten years later, the index tracked ...

Biotech investor Brad Loncar shared with Insider his 10 predictions for 2022. He expected a rebound for biotech stocks after a down year in 2021. He also predicted hot research areas, which CEOs could ...

Over the past two calendar years, acquirers have agreed to pay more than $38 billion to purchase venture-backed companies in ...